Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing
Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Showing 20 of 373 results